US Patent

US10864183 — Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same

Formulation · Assigned to Cydex Pharmaceuticals Inc · Expires 2030-05-28 · 4y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions containing a nitrogen mustard and a cyclodextrin derivative, and methods for making and using them.

USPTO Abstract

The present disclosure is directed to pharmaceutical compositions comprising a nitrogen mustard and a cyclodextrin derivative, and methods of making and using the same.

Drugs covered by this patent

melphalan-hydrochloride (MELPHALAN HYDROCHLORIDE)

Patent Metadata

Patent number: US10864183
Jurisdiction: US
Classification: Formulation
Expires: 2030-05-28
Drug substance claim: No
Drug product claim: Yes
Assignee: Cydex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.